Small-vessel vasculitis following treatment with combination 5-fluorouracil/folinic acid and oxaliplatin

Clinical and Experimental Dermatology

Volumn 34, Issue 1, 2009, Pages 103-105

  Hill, S E ^a   Phillips, R ^a   Francis, N ^a   Agnew, K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; STEROID;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DRUG DOSE REDUCTION; DRUG ERUPTION; ERYTHEMA; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HYPERPIGMENTATION; LEUKOCYTOCLASTIC VASCULITIS; LYMPHOCYTIC INFILTRATION; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN EDEMA; SKIN MANIFESTATION; SKIN PRURITUS; SMALL VESSEL VASCULITIS; STEROID THERAPY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; ORGANOPLATINUM COMPOUNDS; VASCULITIS, ALLERGIC CUTANEOUS;

EID: 57349136286     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02817.x     Document Type: Article

References (5)

1. Martin MJ. Current stage-specific chemotherapeutic options in colon cancer. Expert Rev Anticancer Ther 2005 4 : 695 704.
2. Stevens A. National Institute for Health and Clinical Excellence Technology Appraisal: Irinotecan, Oxaliplatin and Raltitrexed for the Treatment of Advanced Colorectal Cancer, 2005. Available at: http://www.nice.org.uk/TA093 (accessed 10 October 2007).
3. Johnston PG. Stage II colorectal cancer: to treat or not to treat. Oncologist 2005 10 : 332 4.
4. Langford CA. Vasculitis. J Allergy Clin Immunol 2003 111 (Suppl. 2 S602 12.
5. Breathnach SM. Mechanisms of drug eruptions: part 1. Australas J Dermatol 1995 36 : 121 7.